What does PRAC stand for?

Pharmacovigilance Risk Assessment Committee

The Pharmacovigilance Risk Assessment Committee (PRAC) plays a critical role in the medical and pharmaceutical industries by evaluating the risks associated with medicinal products. This committee is responsible for assessing and monitoring the safety profiles of drugs, ensuring that any potential risks are identified and managed effectively. The PRAC's work is vital in safeguarding public health by providing recommendations on the use of medicines across the European Union.

Through its rigorous assessment processes, the PRAC contributes to the continuous improvement of drug safety standards. It collaborates with other regulatory bodies to review data on adverse effects, leading to informed decisions that benefit both healthcare providers and patients. The committee's efforts underscore the importance of pharmacovigilance in maintaining trust in the pharmaceutical industry.